Suitable Australian candidates are being sought for a real-world, Phase 4 diabetic macular oedema (DMO) trial.
InFocus Clinical Research said it was seeking patients who had a diagnosis of DMO within the past two years with no other ocular conditions and well-controlled blood sugars.
Founded by retina specialists, the retinal specialty contract research organisation said it has “established a collaborative network of top clinical investigators as well as an experienced team of Project Managers, Clinical Research Associates, and other specialists to drive ground-breaking research”.
Recruitment for Australian participants in the DMO trial is underway.
To receive further details, visit infocusclinical. com/aus-enrollment.
If the patient details meet the criteria, InFocus said it would “reach out to discuss enrolment options and provide further details about the trial”.
SUPPORT FOR RETINA RESEARCH
With a database of over 550 global retina research sites, InFocus supports many sponsors developing new therapies in retina.
The company does this with services that include online study portals, video production, and mobile app development. Its proprietary systems are optimised for retina studies, streamlining data collection and management of the various assessments involved in research projects. Furthermore, it is able to help optimise research projects from beginning to end with insights on the operational efficiencies, patient enrolments and demographics at various global retina research sites.